Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
publishDate:"[2010 TO 2019]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22
/vufind/Search/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22
Search /vufind/Search2/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22
PubPharm (24.898)
1
Neo-adjuvant pembrolizumab in primary stage IV ovarian cancer : Exploratory study of neo-adjuvant treatment with carboplatin, paclitaxel and pembrolizumab in primary stage IV serous ovarian cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
2
Electrochemotherapy compaired with radiotherapy for the treatment of basal cell carcinoma : Electrochemotherapy versus standard radiatiotherapy for the treatment of basal cell carcinoma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
3
A study investigating the safety and efficacy of intranasal betahistine in patients suffering from vertigo (giddiness) after either the removal of a tumour of the balance and hearing nerve; or where a portion, or all of the inner ear is removed; or where the nerve connecting the inner ear with the brain is cut. : Multicenter randomized controlled phase 2 trial to evaluate AM-125 in thetreatment of acute peripheral vertigo following neurosurgery (TRAVERS) - AM-125 in the treatment of acute peripheral vertigo (TRAVERS)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
4
An open-label, randomized, Phase IV study, to assess the efficacy and safety of tildrakizumab in patients with moderate to severe chronic plaque psoriasis who are non-responders to dimethyl fumarate therapy : An open-label, randomized, Phase IV study, to assess the efficacy and safety of tildrakizumab in patients with moderate to severe chronic plaque psoriasis who are non-responders to dimethyl fumarate therapy - TRANSITION study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
5
A Phase 2 Study to Evaluate the Effectiveness and Safety of ADCT-301 in Patients with Relapsed or Refractory Hodgkin Lymphoma : A Phase 2, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients with Relapsed or Refractory Hodgkin Lymphoma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
6
Stopping treatment along with immune therapy in patients with HIV + who have already been treated with stem cells from each blood cells are formed : Immune Therapy and Analytical Treatment Interruption in HIV+ participants who received an allogeneic stem cell transplantation (ITATI)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
7
Neoadjuvant treatment in rectal cancer with radiotherapy followed by atezolizumab and bevacizumab (TARZAN) : Neoadjuvant treatment in rectal cancer with radiotherapy followed by atezolizumab and bevacizumab (TARZAN) - TARZAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
8
PREDIX HER2 - preoperative treatment of HER2 positive breast cancer : PREDIX HER2 - Neoadjuvant response-guided treatment of HER2 positive breast cancer. Part of a platform of translational phase II trials based on molecular subtypes - PREDIX HER2
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
9
This study is being done to test the effectiveness and safety of an investigational drug called acalabrutinib (ACP-196) when taken with already marketed drugs called Venetoclax and Obinutzumab in comparison to chemotherapy that is already in wide use for treatment of patients who have chronic lymphocytic leukemia and who have never been treated before. : A Randomized, Multicenter, Open-Label, Phase 3 Study to Compare the Efficacy and Safety of Acalabrutinib (ACP-196) in Combination with Venetoclax with and without Obinutuzumab Compared to Investigator’s Choice of Chemoimmunotherapy in Subjects with Previously Untreated Chronic Lymphocytic Leukemia Without del(17p) or TP53 Mutation - Not available at this time
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
10
A clinical research study evaluating the possibility to suspend the drug nilotinib (Tasigna) in chronic myeloid leukemia (CML) patients who have very small amount of leukemia cells remaining after nilotinib (Tasigna) treatment. : A single-arm, multicenter, nilotinib treatment-free remission study in patients with BCR-ABL1 positive Chronic Myelogenous Leukemia in chronic phase who have achieved durable minimal residual disease (MRD) status on first line nilotinib treatment
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[2490]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Erscheinungsjahr: 2010-2019
Medienart
24.898
Aufsätze
24.898
E-Artikel
24.898
E-Ressourcen
Zeitschriftentitel
24.898
WHO International Clinical Trials Registry Plat...
Thema
24.898
610
24.898
Recruitment Status: Authorised-recruitment may ...
24.898
Study Type: Interventional
4.792
Phase: Phase 3
3.538
Phase: Phase 2
1.792
Phase: Phase 4
768
Phase: Phase 1
26
Medical Condition: Moderately to Severely Activ...
22
Medical Condition: Crohn's disease;Therapeutic ...
20
Medical Condition: Non-Small Cell Lung Cancer;T...
16
Medical Condition: Ulcerative colitis MedDRA ve...
16
Medical Condition: Ulcerative colitis MedDRA ve...
14
Medical Condition: Locally Advanced or Metastat...
14
Medical Condition: Moderately to Severely Activ...
14
Medical Condition: Multiple Myeloma MedDRA vers...
12
Medical Condition: High Risk Neuroblastoma;Ther...
12
Medical Condition: Moderately to Severely Activ...
12
Medical Condition: Trigeminal Neuralgia MedDRA ...
12
Medical Condition: Ulcerative Colitis MedDRA ve...
10
Medical Condition: ;Therapeutic area: Diseases ...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2010-2019
5.166
2019
2.762
2018
1.864
2017
1.648
2016
1.684
2015
1.774
2014
1.354
2013
8.646
2012
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
21.742
Englisch
1.036
Französisch
810
Unbestimmt
790
Spanisch
148
Finnisch
110
Deutsch
66
Schwedisch
50
Niederländisch
40
Dänisch
36
Italienisch
26
Galizisch
12
Ungarisch
8
Tschechisch
8
Norwegisch
4
Isländisch
2
Estnisch
2
Indonesisch
2
Irisch
2
Latein
2
Slowakisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...